Evidence map›Paper›PMID 23110169›Full record

ArticlePloS one2012

Transforming growth factor Beta 3 is required for excisional wound repair in vivo.

Mark Le, Rachelle Naridze, Jasmine Morrison, Leah C Biggs, Lindsey Rhea, Brian C Schutte, Vesa Kaartinen, Martine Dunnwald

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. ARHGAP29 promotes keratinocyte proliferation and migration in vitro and is dispensable for in vivo wound healing.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Wound Healing Potential and In Silico Appraisal ofBioMed research international · 2022
    Article
  17. Article
  18. Review
  19. Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mark LeDepartment of Pediatrics, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, United States of America.
Rachelle Naridze
Jasmine Morrison
Leah C Biggs
Lindsey Rhea
Brian C Schutte
Vesa Kaartinen
Martine Dunnwald
University of Iowa · USMichigan United · US

Funding

PHENOTYPE AND GENETICS IN OROFACIAL CLEFT FAMILIESP50DE016215 · NIDCR · UNIVERSITY OF IOWA · PI LOVETT, MICHAEL · 2004 to 2008
$10.1M
Role of Interferon Regulatory Factor 6 (Irf6) in cutaneous wound healingR03AR055313 · NIAMS · UNIVERSITY OF IOWA · PI DUNNWALD, MARTINE · 2008 to 2010
$224k
NIAMS NIH HHS AR055313NIAMS NIH HHS R03 AR055313NIDCR NIH HHS DE16215NIDCR NIH HHS P50 DE016215
6 · The paper itself

Abstract

Wound healing is a complex process that relies on proper levels of cytokines and growth factors to successfully repair the tissue. Of particular interest are the members of the transforming growth factor family. There are three TGF-ß isoforms-TGF- ß 1, 2, and 3, each isoform showing a unique expression pattern, suggesting that they each play a distinct function during development and repair. Previous studies reported an exclusive role for TGF-ß 3 in orofacial development and a potent anti-scarring effect. However, the role of TGF- ß 3 in excisional wound healing and keratinocyte migration remains poorly understood. We tested the effect of TGF-ß 3 levels on excisional cutaneous wounds in the adult mouse by directly injecting recombinant TGF-ß 3 or neutralizing antibody against TGF-ß 3 (NAB) in the wounds. Our results demonstrate that TGF-ß 3 does not promote epithelialization. However, TGF-ß 3 is necessary for wound closure as wounds injected with neutralizing antibody against TGF-ß 3 showed increased epidermal volume and proliferation in conjunction with a delay in keratinocyte migration. Wild type keratinocytes treated with NAB and Tgfb3-deficient keratinocytes closed an in vitro scratch wound with no delay, suggesting that our in vivo observations likely result from a paracrine effect.

Indexed as

Wound HealingAnimalsAntibodies, NeutralizingCell MovementCell ProliferationCells, CulturedCicatrixEpitheliumFemaleImmunohistochemistryKeratinocytesMaleMiceMice, Inbred C57BLMice, TransgenicRecombinant ProteinsAntibodies, NeutralizingRecombinant ProteinsTgfb3 protein, mouseTransforming Growth Factor beta3

Identifiers

PMID23110169
PMCPMC3482237
OpenAlexW2012048902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.